Differential control of mycobacteria among COVID-19 patients is associated with CD28+ CD8+ T cells
Alba Llibre, Henna Siddiqui, Julie G. Burel, Jamie Pillaye, Nick D. Jones, Harriet J. Hill, Sian Elizabeth Faustini, Ella F Windle, Hanfa Karim, Emma Sherry, Christopher A Green, Martin J Dedicoat, Zania Stamataki, Adam F. Cunningham, Matthew K. O’Shea
The paper examines how CD28+ CD8+ T cells in COVID-19 patients influence mycobacterial growth inhibition.
Clinical Immunology · Jun 6, 2025Peer-reviewedImmunology